Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A conversation between two extremely knowledgeable prostate cancer advocates in comments on an earlier post has highlighted the underlying problem of what we mean by “over-diagnosis” and “over-treatment” of prostate cancer in a highly educational manner.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: over-diagnosis, over-treatment, risk | 9 Comments »
Two recent publications have offered evidence that, at 10 and 12 years of follow-up, the potential benefits of surgical treatment for low- and intermediate-risk prostate cancer did not include any impact on overall survival for men of 65 years of age or more at the time of surgery.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: benefit, complication, elderly, localized, outcome, over-treatment, risk, side effect | 2 Comments »
In recent years, it has become increasingly well understood that patients diagnosed with low-risk prostate cancer are potentially susceptible to over-treatment. This is particularly the case among men who have significant degrees of co-morbidity and men greater than 75 years of age who have a life expectancy of < 15 years.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Charlson score, Co-morbidity, low risk, over-treatment, risk | Leave a Comment »
There is a good deal of media noise today about a newly published study in Archives of Internal Medicine. The study addresses the “risk profiles and treatment patterns” of US prostate cancer patients diagnosed with a PSA of ≤ 4.0 ng/ml.”
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Diagnosis, low risk, over-treatment, PSA, Treatment | 7 Comments »
Are we over-treating 50,000 men each year? Could it be even more?
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: over-treatment, PSA, risk | 22 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site